Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02792296 · ClinicalTrials.gov registry record · NA
Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements
A NA study, sponsored by Akili Interactive Labs.
- Completed
- Registry status
- NA
- Development phase
- 71
- Enrollment target
NCT02792296 is a NA study that has completed, run by Akili Interactive Labs. The registered enrollment target is 71 participants.
The verdict
NCT02792296, a NA study, has completed, sponsored by Akili Interactive Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
Study Summary
This is an open-label study in adults to assess at-home Project: EVO Monitor measurements over repeat play cycles. The study has three arms:playing multiple times per day, once daily, and once weekly for 4 to 8 weeks.
Interventions
- OTHER Project: EVO Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02792296
The ClinicalTrials.gov registry entry for NCT02792296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Project: EVO Monitor is the first listed.
NCT02792296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02792296 about?
NCT02792296 is a clinical study titled "Feasibility & Characterization of Project: EVO Monitor Cognitive Measurements". This is an open-label study in adults to assess at-home Project: EVO Monitor measurements over repeat play cycles. The study has three arms:playing multiple times per day, once daily, and once weekly for 4 to 8 weeks.
What is the current status of trial NCT02792296?
This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2016-06. Estimated completion is 2016-11.
What interventions are being tested in trial NCT02792296?
The interventions under investigation include: Project: EVO Monitor (OTHER).
Who is sponsoring clinical trial NCT02792296?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.